MSB 2.58% 94.5¢ mesoblast limited

Cell Therapy News/Articles, page-78

  1. 6,121 Posts.
    lightbulb Created with Sketch. 1055
    Smith & Nephew to purchase regenerative medicine company for $210M: 3 points

    Written by Mackenzie Garrity | Tuesday, 24 October 2017 20:44
    Social sharing

    Smith & Nephew plans to acquire Minnesota-based Rotation Medical, a developer of regenerative medicine technologies for patients suffering from rotator cuff disease, for $210 million, according to Reuters.

    Here are three points:

    1. Smith & Nephew will pay $125 million upfront followed by $85 million over the next five years if certain financial targets are met.

    2. The deal is supposed to close later this year, and while the purchase is not supposed to boost Smith & Nephew's earnings in 2018, the company expects earnings to increase in 2019.

    3. Rotation Medical develops tissue regeneration technology for shoulder rotator cuff repair. The sale of the company is cleared in the U.S. and a filing is being prepped in Europe.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
94.5¢
Change
-0.025(2.58%)
Mkt cap ! $1.078B
Open High Low Value Volume
98.0¢ 98.5¢ 94.0¢ $2.482M 2.602M

Buyers (Bids)

No. Vol. Price($)
6 71720 94.0¢
 

Sellers (Offers)

Price($) Vol. No.
94.5¢ 10463 1
View Market Depth
Last trade - 16.10pm 06/09/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.